The company reported a net loss of $148 million for FY26, driven by increased R&D and administrative expenses as it advanced its lead programs HLP003 and HLP004 through late-stage clinical trials. Cash reserves rose to $157 million following major equity financings, with topline Phase 3 data for HL…
FDA approved Lumvoa for both active and chronic thyroid eye disease, supported by robust phase 3 data showing rapid and durable symptom reduction. Immediate launch is planned, with comprehensive patient support and safety monitoring guidelines in place.Original document: Viridian Therapeutics, Inc…
Continuous near-surface copper mineralization has been confirmed over 6.7 km at Dumbwa, with recent drilling extending the strike and returning notable intercepts such as 21.64m @ 0.42% Cu and 13.67m @ 0.51% Cu. Systematic drilling and robust QA/QC support the project's scale and potential.Original…
Transitioned key assets from exploration to development, highlighted by the acquisition and rapid advancement of the Amghas antimony mine in Morocco and the Silverking copper-silver project in Zambia. Net loss widened to £2.04m due to increased exploration and impairment charges, while cash flow re…
The acquisition of KARE strengthens the group’s position in U.S. real estate, diversifies income, and enhances scale, with strong cultural fit and significant cross-sell potential. The deal is highly accretive, expected to close by year-end, and positions the group for further growth and margin exp…
The acquisition combines launch, manufacturing, and global satellite communications, creating a vertically integrated space leader. The $8 billion deal is expected to be highly accretive, accelerate market entry, and unlock new recurring revenue streams.Based on Rocket Lab Corporation [RKLB] M&A an…
A $13.5 billion combination will create the nation's leading lime and limestone producer, expanding geographic reach and product offerings while targeting $85 million in annual cost synergies. The deal is expected to be accretive in the first year and close in the second half of 2026.Original docum…
A $13.5B merger will create a U.S. leader in aggregates, lime, and industrial minerals, with $85M in annual cost synergies expected within two years and a focus on high-growth markets. The deal aligns with long-term strategic goals and is set to close in H2 2026, pending regulatory approval.Origina…
Double-digit growth in EBITDA, EPS, and DPS was achieved, with AUM reaching £13.0bn and strong fundraising across institutional and retail channels. The sale of the public markets division enables a sharper focus on Real Assets and Private Equity, with guidance reaffirmed for continued margin expan…
Flex workspace has become a core strategy, with a future-ready platform and proprietary technology driving productivity and adaptability. Data-driven design, operational excellence, and a focus on member experience have resulted in high loyalty and sustained growth.Original document: WeWork India M…
A $8B acquisition merges launch and satellite manufacturing with a global communications network, creating a vertically integrated space company. The deal is expected to close in mid-2027, delivering recurring revenue, cost synergies, and expanded market reach.Original document: Rocket Lab Corporat…
A transformative acquisition combines launch, manufacturing, and global satellite communications, creating a vertically integrated space leader. The $8B deal, closing mid-2027, accelerates market entry, unlocks new services, and secures valuable spectrum rights.Original document: Rocket Lab Corpora…
Rolling BLA submission for nomlabofusp has begun, with FDA alignment on the data package and FXN as a surrogate endpoint. Open label study data show sustained FXN increases and clinical improvements at 1 year and 18 months, with a favorable safety profile. Global Phase 3 trial is set to start dosin…
Q2 saw strong passenger and cargo growth, with higher yields offsetting increased fuel costs. Demand remains robust, supported by both market momentum and supply constraints, while management continues to focus on fleet renewal and strategic flexibility amid ongoing geopolitical uncertainties.Based…
Accelerated growth in the pet food sector is driven by expertise in marine products, strategic acquisitions, and expansion into Southeast Asia. Market trends such as pet humanization and premiumization support strong, sustainable growth, with significant opportunities in Asia.Original document: Umi…
Revenue more than doubled year-over-year, while net loss narrowed significantly due to lower non-cash impairments and fair value losses. Strong presales and capital raising activities improved liquidity and positioned the group for future growth, especially in residential development.Original docum…
Q2 saw strong traffic and revenue growth, with higher yields offsetting increased fuel costs. Demand remains robust, but guidance stays wide due to geopolitical uncertainties. Strategic focus is on network optimization, fleet renewal, and maintaining flexibility.Based on Finnair Oyj [FIA1S] Pre-sil…
The acquisition adds YUPELRI® and diversified assets, providing immediate and growing cash flows, with a $929 million deal financed through innovative non-recourse structures. The transaction is expected to close in H2 2026, supporting long-term growth and shareholder value.Original document: Zymew…
FDA alignment supports a rolling BLA submission for nomlabofusp in Friedreich's ataxia, with positive open-label data showing sustained FXN increases and clinical improvements over 1–18 months. Safety profile remains consistent, and Phase 3 dosing is planned for Q3 2026.Original document: Larimar T…
A definitive agreement was reached to acquire a major talent consulting firm for £850 million ($1.1 billion) in cash and stock, creating a global leader with over 16,000 employees and expanded capabilities. The deal is expected to close in FY'27 Q2 and be immediately accretive to EPS.Original docum…
